Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.75
+0.02 (0.19%)
Aug 21, 2026, 4:00 PM EDT - Market closed
DMAA Market Cap
DMAA has a market cap or net worth of $260.98 million as of August 21, 2026. Its market cap has decreased by -24.11% in one year.
Market Cap
260.98M
Enterprise Value
261.31M
1-Year Change
-24.11%
Ranking
Category
Stock Price
$10.75
ChartMarket Cap Chart
Since the IPO on January 28, 2025, DMAA's market cap has decreased from $291.71M to $260.98M, a decrease of -10.54%. That is a compound annual growth rate of -6.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 260.98M | -24.94% |
| Dec 30, 2025 | 347.71M | 19.20% |
| Jan 28, 2025 | 291.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jones Ventures INTL Acquisition1 | 270.93M |
| Dynamix Corporation III | 269.94M |
| Oaktree Acquisition Corp. III Life Sciences | 265.99M |
| FACT II Acquisition | 259.27M |
| TRG Latin America Acquisitions | 258.33M |
| Vendome Acquisition Corporation I | 256.75M |
| InterPrivate Investment Partners V | 252.34M |
| Catalyst Acquisition | 252.07M |